Nephrology Dialysis Transplantation

Papers
(The TQCC of Nephrology Dialysis Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
MO239ORAL FUNGAL INFECTION IN ESRD PATIENTS 144
#3848 ORIGIN TRIAL: 24-WK PRIMARY ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PH2B STUDY OF ATACICEPT IN PATIENTS WITH IGAN121
MO192ASYMPTOMATIC HYPERURICEMIA AS A RISK FACTOR OF OUTCOME IN CARDIORENAL PATIENTS111
MO104RISK OF END-STAGE RENAL DISEASE: PREDICTION USING CUMULATIVE NUMBER OF HYPERTENSION DIAGNOSES103
FC 103PROTEOME WIDE OXIDATIVE STRESS PROFILING IN MESOTHELIAL CELLS INDUCED BY PERITONEAL DIALYSIS FLUID96
MO415DOES LOW CONTRAST VOLUMES REDUCE RATES OF CONTRAST-INDUCED NEPHROPATHY IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY?88
MO112SYSTEMIC OXALOSIS IN PRIMARY HYPEROXALURIA TYPE 3 – ARE THE PATIENTS AT RISK?86
MO366CONCORDANCE BETWEEN FIVE CLASSIFICATION SYSTEMS OF COMMUNITY-ACQUIRED ACUTE KIDNEY INJURY80
FHL2 in arterial medial calcification in chronic kidney disease67
MO382POTASSIUM DISTURBANCES AND CHARACTERISTICS OF RENAL RECOVERY IN 1519 CONSECUTIVE PATIENTS WITH ACUTE KIDNEY INJURY67
MO750THE COMBINED PROGNOSTIC SIGNIFICANCE OF ALKALINE PHOSPHATASE AND INTRA-CRANIAL ARTERIAL CALCIFICATIONS IN HEMODIALYSIS PATIENTS65
FC 110PTH INDCUED ENDMT VIA MIR-29A-5P/GSAP/NOTCH1 PATHWAY CONTRIBUTED TO VALVULAR CALCIFICATION IN RATS WITH CKD55
MO844COVID-19 PANDEMIC IN DIALYSIS PATIENTS IN SWITZERLAND52
MO1019ASSOCIATION OF VEGF ANF TGF1 GENES POLYMORPHISMS WITH SERUM CONCENTRATION OF GENE PRODUCTS  IN CHILDREN WITH LUPUS NEPHRITIS51
MO961KIDNEY TRANSPLANTATION AS A TREATMENT OF CHOICE FOR AA AMYLOIDOSIS DUE TO PERIODIC FEVER SYNDROME50
MO223MEMBRANOUS NEPHROPATHY ASSOCIATED TO ANKYLOSING SPONDYLITIS: CASE REPORT45
MO1032HISTORY OF THE PARADIGMS OF INFLAMMATION IN KIDNEY DISEASES44
MO122SEX DIFFERENCES IN THE RISK OF KIDNEY STONES43
Erratum to: FC041 tubular epithelial cell polyploidy is essential to survive AKI but contributes to CKD progression42
MO813ANALYSING TRANSITIONS IN THE INTEGRATED MODEL OF RENAL REPLACEMENT THERAPY IN A REGIONAL HEALTH SYSTEM42
MO746CARDIAC REMODELING AND PULMONARY HYPERTENSION IN HEMODIALYSIS PATIENTS41
Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients40
MO048: Genome-wide studies reveal factors associated with circulating uromodulin and its relations with complex diseases39
FC 074POOLED EFFICACY AND CARDIOVASCULAR SAFETY RESULTS OF 3 PLACEBO-CONTROLLED AND 1 DARBEPOETIN ALFA-CONTROLLED STUDIES OF ROXADUSTAT FOR TREATMENT OF ANAEMIA IN PATIENTS WITH NON-DIALYSIS-DEPENDENT39
MO841: Anxiety and Depression in Maintenance Hemodialysis Patients: Prevalence and Their Effects on Health-Related Quality of Life39
MO869: SARS-COV-2 Neutralizing Antibodies in Patients on Hemodialysis After Vaccination39
MO675: A New in Vivo Multi-Photon Microscopy Based Approach to Study the Peritoneal Membrane Changes Induced by Peritoneal Dialysis38
MO826: Long-Term Impact of COVID-19 Pandemic on HD Adequacy and Patient Care in Alexandria, Egypt: A Multi-Centre Study37
MO405: Leucine-Rich Alpha-2-Glycoprotein as a Potential Marker of Mesangial Cell Proliferation in Immunoglobulin a Nephropathy36
MO916: Anxiety and Depression Among Dialysis Centre Staff and Haemodialysis Patients During the COVID-19 Pandemic36
MO144: Behind the Scenes: A Year in an Onco-Nephrology Outpatient Clinic in Italy36
FC033: Genome-Wide Association Meta-Analysis Identifies Novel Loci for Kidney Failure35
MO766: Sodium Citrate Versus Heparin Locking Solutions for Tunnelled Haemodialysis Catheters: A Retrospective Analysis35
MO1005: Analysis of Expression of Immune System Genes that are Responsible for Activation and Inhibition of T-Cell Immune Response in Renal Transplant Recipients after Extracorporeal Photochemotherapy35
FC089: The Absence of Sting Prevents Peritoneal Damage in a Murine Model of Peritoneal Fibrosis34
MO275: A Biomarker of Acute Kidney Injury from Proven Renal Origin34
MO998: Kidney Donor Risk Index Correlates with the Worse Recipients And Grafts Survival in a Polish Cohort34
FC029: A Multivariate Model Identifies Genotype, Hypertension and Kidney Length as Independent Baseline Predictors of Disease Progression in a Longitudinal Autosomal Dominant Polycystic Kidney Disease33
MO081: Ambulatory Blood Pressure Trajectories and Blood Pressure Variability in Kidney Transplant Recipients: A Comparative Study Against Chronic Kidney Disease Patients33
FC006: Sex Differences in the Recognition, Monitoring and Management of Chronic Kidney Disease in Health Care32
FC077: Cystatin C Testing Improves Risk Stratification Associated with Chronic Kidney Disease Without Adopting Age-Adapted Diagnostic Thresholds: A UK Biobank Study31
MO1019: Sigma-1 Receptor Agonists are Protective in a Rat Model of Kidney Transplantation30
MO197: Change in the Level Of NFKBP65 Gene Expression in the Myocardium and Kidneys of Wistar Rats and Spontaneously Hypertensive Rats (SHR) That Received Diet Rich in NACL30
MO142: Urinary Hemopexin  As a Marker of Lupus Activity Among Egyptian SLE Patients with Proliferative Lupus Nephritis30
MO490: Fast and High Phosphate Reduction With Lanthanum Dioxycarbonate Versus Selevamer In In-Vivo Study29
MO1029: Is there a Relationship Between Fibroblast Growth Factor 23 and Blood Pressure in Children with Chronic Kidney Disease?28
MO522: The Effect of Statin on Anemia in Patients With End-Stage Kidney Disease Receiving Hemodialysis: A Systematic Review and Meta-Analysis28
MO273: Water Restriction and Age Increase the Risk of Triple Whammy-Induced Acute Kidney Injury28
MO753: Marinobufagenin Predicts Intradialytic Hypotension Episodes in Prevalent Haemodialysis Patients27
MO550: Vascular Cells Senescence and Modifications in NRF2 Pathway in a Model of URaEMIC Vascular Calcification27
MO227: Anca-Associated Vasculitis Following Pfizer-Biontech COVID-19 Vaccine: True Association or Circumstantial?26
MO556: Markers of Oxidative Stress and Coronary Calcifications in Chronic Hemodialysis Patients26
#3261 SAR131675, A SELECTIVE VEGFR3 INHIBITOR, AMELIORATES RENAL INFLAMMATION AND LYMPHANGIOGENESIS IN THE MURINE LUPUS NEPHRITIS MODEL26
MO064ASSESSMENT OF KIDNEY SURVIVAL IN PATIENTS AFFECTED BY ADPKD26
MO688: Peritoneal Protein Clearance, Inflammation, Nutrition and Overhydration in PD Patients: Looking for the Culprit26
FC 008INTERDEPENDENT REGULATION OF POLYCYSTIN EXPRESSION INFLUENCES STARVATION-INDUCED AUTOPHAGY AND CELL DEATH26
MO708: Association of Atherogenic Index of Plasma (AIP) with Mortality in Chinese and Swedish End-Stage Kidney Disease Patients: Results from Two Cohorts26
#6848 DIABETES AND HEMODIALYSIS ARTERIOVENOUS ACCESS CONSTRUCTION – A RETROSPECTIVE STUDY IN A SINGLE CENTER25
#5599 FEBUXOSTAT IN COMBINATION WITH ANAKINRA OR PH NEUTRALIZATION IMPROVE THE OUTCOMES IN HYPERURICEMIA-RELATED URIC ACID CRYSTALLURIA IN MICE25
#3121 THE EFFECTIVENESS OF A GLUTEN-FREE DIET IN PATIENTS WITH IGA NEPHROPATHY25
#3166 RECOGNITION OF RENAL TUBULAR DYSGENESIS IN ADOLESCENT CKD BY BIALLELIC AGT VARIANTS REQUIRED BROAD GENETIC ANALYSIS25
#5882 BENEFIT OF LONG-TERM TOLVAPTAN ADMINISTRATION ON KIDNEY DISEASE PROGRESSION IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE-CENTRE EXPERIENCE24
#5285 SERUM IRON AND NUTRITIONAL STATUS ARE ASSOCIATED IN PATIENTS WITH CHRONIC KIDNEY DISEASE23
#3144 KIDNEY TRANSPLANT-RELATED KNOWLEDGE AMONG SOUTH ASIAN COMPARED TO WHITE CANADIAN PATIENTS23
#4720 SEPSIS, AKI AND MORTALITY. SEARCHING FOR NEW MARKERS: OUR EXPERIENCE WITH ENDOGENOUS OUABAIN23
#2685 SLC34A2 EXACERBATES TUBULAR INTERSTITIAL FIBROSIS VIA INDUCTION OF APOPTOSIS AND CELL CYCLE ARREST IN S PHASE23
#2531 AGATSTON INDEX AS A PREDICTOR OF PREDICTION OF THE DEGREE OF HEART VASCULAR DAMAGE IN STAGE 5 CKD PATIENTS RECEIVING PROGRAM HEMODIALYSIS23
#4127 MODULATION OF BLOOD PRESSURE THROUGH MICROBIOME EXCHANGE BETWEEN MILAN NORMOTENSIVE AND HYPERTENSIVE STRAINS OF RATS22
#4264 PERITONEAL DIALYSIS AFTER FAILED KIDNEY TRANSPLANT: A SUITABLE OPTION22
#4758 IMPACT OF GENDER ON CHRONIC KIDNEY DISEASE IN ELDERLY22
#5510 CKD-ASSOCIATED PRURITUS SEVERITY AND ITS ASSOCIATION WITH BODY DISTRIBUTION AND EQ-5D HEALTH-RELATED QUALITY OF LIFE IN HAEMODIALYSIS PATIENTS22
#5142 THE NATURAL HISTORY OF FSGS IN THE GERMAN CHRONIC KIDNEY DISEASE (GCKD) COHORT22
#6005 COMPARISON OF SEMAGLUTIDE ORAL VS SUBCUTANEOUS IN CHRONIC KIDNEY DISEASE (CKD)22
#5645 SHORT-CHAIN FATTY ACIDS, PROPIONATE AND BUTYRATE, RESEMBLE THE BENEFICIAL EFFECTS OF VITAMIN D DURING ACUTE KIDNEY DAMAGE22
#3641 DOES IBANDRONATE OR CALCIUM AND VITAMIN D MAINTAIN OR IMPROVE BONE MICROARCHITECTURE IN THE FIRST YEAR AFTER KIDNEY TRANSPLANTATION?22
#3140 THE WEST OF SCOTLAND AND THROMBOTIC MICROANGIOPATHY21
#3812 ARE KIDNEY CYSTS MORE COMMON IN PEOPLE WITH COL4A3/COL4A4 PATHOGENIC VARIANTS?21
#3296 ADVERSE MUSCLE COMPOSITION ASSESSED BY MRI ASSOCIATES TO POOR FUNCTIONAL PERFORMANCE AND METABOLIC COMORBIDITIES IN CKD21
MO443EFFECTS OF SHORT-TERM POTASSIUM CHLORIDE SUPPLEMENTATION IN PATIENTS WITH CHRONIC KIDNEY DISEASE*21
#4176 ROLE OF KIDNEY FUNCTION ON NRF2 MRNA LEVELS IN TYPE-2 DIABETES21
MO892DIALYSIS SERVICE MANAGEMENT DURING COVID-19 PANDEMIC IN EUROPEAN CITY AREA21
#6279 ESKD TREATMENTS: A DIFFICULT CHOICE TO ELDERLY PATIENTS?21
MO436PLASMA OXALATE VALUES IN PATIENTS WITH END-STAGE KIDNEY DISEASE20
#4554 FRAX® ASSOCIATION, BONE DENSITOMETRY, BIOCHEMICAL PARAMETERS OF BONE MINERAL METABOLISM AND ADVANCED CHRONIC KIDNEY DISEASE20
MO354PRELIMINARY EVIDENCE OF RIVASTIGMINE EFFICACY IN CKD RELATED MILD COGNITIVE IMPAIRMENT19
MO870HYPOCHLOREMIA IS ASSOCIATED WITH A GREATER INCIDENCE OF PNEUMONIA IN CHRONIC HEMODIALYSIS PATIENTS WITH COVID-19: A CENTER'S EXPERIENCE19
MO651DIABETES CARE IN HAEMODIALYSIS TREATMENT : ADVANCES IN 202019
#2528 APOL1 GENOTYPING AND PROTEINURIC KIDNEY DISEASE IN EUROPE19
MO693EXERCISE TOLERANCE AND NUTRITIONAL STATUS PREDICTS ALL-CAUSE MORTALITY IN OLDER ADULTS ON PERITONEAL DIALYSIS: A SINGLE-CENTER PROSPECTIVE OBSERVATIONAL COHORT STUDY19
MO794EVALUATION OF THE BONE ELASTIC STRUCTURE IN PERSONS WITH AND WITHOUT CHRONIC KIDNEY DISEASE ON DIALYSIS19
MO1017PSYCHOSOCIAL REPERCUSSIONS AND QUALITY OF LIFE OF CHILDREN UNDERGOING HEMODIALYSIS IN A DEVELOPING COUNTRY19
#4585 POST-TRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER: COMPARISON OF RISK AND PROGNOSTIC FACTORS BETWEEN KIDNEY AND OTHER ORGAN TRANSPLANT RECIPIENTS19
Functional adaptation after kidney tissue removal in patients is associated with increased plasma atrial natriuretic peptide concentration19
#3303 SUBOPTIMAL EXTENT OF RAASI RE-INITIATION AFTER DISCONTINUATION FOLLOWING HYPERKALEMIA: AN OBSERVATIONAL STUDY OF CARDIORENAL PATIENTS IN THE US AND JAPAN19
Quantifying the benefits of remission duration in focal and segmental glomerulosclerosis19
MO647RENOPROTECTIVE EFFECT OF SGLT2 INHIBITORS AFTER FIVE YEARS OF TREATMENT: AN OBSERVATIONAL STUDY19
#3968 DIFFERENCES IN MENTAL HEALTH STATUS DURING COVID-19 PANDEMIC BETWEEN IN-CENTER HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS18
#2868 PREDICTION OF MAJOR GASTROINTESTINAL BLEEDING EVENTS IN HEMODIALYSIS18
#6368 PLATELET TO LYMPHOCYTE RATIO AND SICKLE CELL NEPHROPATHY18
#6668 PREDICTION OF REMAINING RENAL FUNCTION IN PATIENTS UNDERGOING RADICAL NEPHRECTOMY DUE TO RENAL TUMOUR MASS AND AFTER NEPHRECTOMY IN LIVING DONORS18
#2728 THROMBOINFLAMMATORY BIOMARKERS AND THEIR RELATIONSHIP WITH CIRCULATING GLYCOSAMINOGLYCANS IN END-STAGE RENAL DISEASE PATIENTS18
#5958 VALUE OF EXOME SEQUENCING “FIRST” FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE18
#6891 MACHINE LEARNING NEPHROPATHOLOGY DIAGNOSTICS OF THROMBOTIC MICROANGIOPATHIES18
#6456 DSA-NEGATIVE MICROVASCULAR INFLAMMATION IN KIDNEY TRANSPLANT BIOPSIES: GENE EXPRESSION COMPARISON WITH NATIVE AND TRANSPLANT KIDNEY CONTROLS18
#6120 MIRNA PROFILING OF URINARY EXTRACELLULAR VESICLES (EVS) IN TBMN AND CFHR5 NEPHROPATHY FOR THE IDENTIFICATION OF NOVEL DISEASE BIOMARKERS18
#6442 HOW CAN IT BE NEPHROANGIOSCLEROSIS? HE´S BEING TREATED ONLY WITH ONE ANTIHYPERTENSIVE DRUG18
#6672 THE DEVELOPMENT OF A COMMUNITY-NEPHROLOGY, MULTI-DISCIPLINARY SERVICE18
#5730 PERLECAN AS A POTENTIAL BIOMARKER OF CARDIOVASCULAR RISK: ROLE OF ENDOTHELIAL GLYCOCALYX IN CHRONIC KIDNEY DISEASE18
#4063 APELIN INCREASES FOREARM BLOOD FLOW IN CHRONIC KIDNEY DISEASE18
#5785 ACUTE KIDNEY INJURY AS A RISK FACTOR FOR THE DEVELOPMENT OF CHRONIC KIDNEY DISEASE AND MORTALITY IN HOSPITALIZED PATIENTS18
#5532 COVID-19 INFECTION MODIFIES GLOMERULAR DISEASE EVOLUTION17
#3958 PROTON PUMP INHIBITORS AND THE RISK OF ACUTE KIDNEY INJURY IN PATIENTS RECEIVING IMMUNE CHECKPOINT INHIBITORS: A POPULATION-BASED COHORT STUDY17
Age and gender differences in symptom experience and health-related quality of life in kidney transplant recipients: a cross-sectional study17
Pediatric kidney care experience after the 2023 Türkiye earthquake17
#6915 IMMUNOLOGIC EFFECTS OF THE DECREASE OF IMMUNOSUPPRESSION AFTER SARS-COV-2 INFECTION IN KIDNEY TRASPLANT RECIPIENTS17
#5448 INCIDENCE OF ACUTE PULMONARY EDEMA AFTER THE SYSTEMATIC USE OF ULTRASOUND B-LINES17
Hippocampal subfield morphology in regular hemodialysis patients17
Neutralizing the IL-7Rα limits injury in experimental ANCA-associated glomerulonephritis17
MO489GESTATIONAL DIABETES AND THE LONG-TERM RISK OF MATERNAL KIDNEY DISEASE: A SWEDISH NATIONAL COHORT STUDY17
#5349 CYCLIN D1 AMELIORATES ACUTE KIDNEY INJURY BY IMPROVING FATTY ACID OXIDATION VIA AMPK PATHWAY17
#6896 A SCREENING AND CLINICAL MANIFESTATIONS OF FABRY DISEASE IN PATIENTS ATTENDING DIALYSIS AND NEPHROLOGY CLINICS IN DURBAN, SOUTH AFRICA17
FC051: Atacicept Reduces Serum ANTI-GD-IGA1 Levels in IgAN Patients17
Plasma endotrophin, reflecting tissue fibrosis, is associated with graft failure and mortality in KTRs: results from two prospective cohort studies17
MO791HIGH-SENSITIVITY CARDIAC TROPONIN I CORRELATES WITH THE CARDIAC DYSFUNCTION AND WITH THE SEVERITY OF ANEMIA IN DIALYSIS PATIENTS17
MO380: Bio-Conductivity Measurement for Electrical Impedance Tomography (EIT) in Chronic Kidney Disease—A Non-Invasive and Portable Monitoring Approach16
Cognitive deficits associate with cerebral hypoxia during hemodialysis16
Peer-reviewing and medical publication16
Chosing the best renal care for our patients: the evolving landscape of dialysis therapy16
Phosphorus balance calculator: an individualized tool for treatment of hyperphosphatemia in hemodialysis patients16
Immunoengineering for autoimmune-kidney disease16
#5536 CIRCULATING LEVELS OF COPEPTIN, GROWTH DIFFERENTIATION FACTOR 15 (GDF15) AND INTERLEUKIN 6 (ILA-6) IN PATIENTS WITH ADVANCED KIDNEY DISEASE16
#2745 New strategies for capturing undiagnosed chronic kidney disease in patients at risk16
Anti-C1Q monitoring predicts relapses of lupus nephritis16
#1914 Comprehensive single-cell sequencing and lipidomics identify diverse injury states and cholesterol dynamics of the PTs in AKI-to-CKD transition16
Correction to: CKD therapy to improve outcomes of immune-mediated glomerular diseases16
#821 Kibra mediates the activation of hippo by classic signal pathway related to NPHP1 defect15
#1315 Management and long-term outcome of recurrent idiopathic FSGS in pediatric renal transplant recipients15
#2118 Monitoring hemodynamics in dialysis: on the feasibility of semi-continuous and multifrequency thoracic bioimpedance measurements by a wearable device15
#1936 Investigating genetic and environmental modifiers of autosomal dominant polycystic kidney disease through a distinct PKD2-founder variant (p.Arg803*)15
#2963 Light chain deposition in the kidney is more frequent in patients with proliferative lupus nephritis15
#1157 Body mass and fluid balance in dialysis: global profiles in Apollo Dial DB15
#3140 Investigating the impact of Anti-IL5 therapy in eosinophilic granulomatosis with polyangiitis (EGPA): a three year longitudinal perspective15
#598 Successful application of allo-hemodialysis in a porcine model of embolization-induced acute kidney injury15
#2740 Pregnancy outcomes in patients with IgA nephropathy and the impact of pregnancy on the renal disease15
#2251 Long-term systolic blood pressure variability as an independent risk factor for cardiovascular events in kidney transplant recipients15
#2294 Muscle ultrasound as a tool for morphofunctional assessment in patients with chronic kidney disease15
#606 Impact of real-world off-label dose of apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease15
#1906 Lung ultrasound as a valid tool for fluid assessment in dialysis patients: a systematic review15
#860 The role of immunocorrection in the treatment of patients chronic pyelonephritis14
#1704 GLP-1RA versus DPP-4 inhibitors and rates of hyperkalemia and discontinuation of renin-angiotensin system (RAS) blockade in Swedish routine care14
#543 Cognitive improvement in end stage renal disease patients post transplantation—a prospective observational study14
#814 Inflammatory biomarkers and progression of diabetic kidney disease14
#1048 Why are felids at such a high risk of chronic kidney disease?14
#761 Effect of ketoanalogue-supplemented very low protein diet in the need to initiate renal replacement in chronic kidney disease patients14
#2394 Inhibition of ACSS2-mediated H3K9 crotonylation alleviates kidney fibrosis via IL-1β-dependent macrophage activation and tubular cell senescence14
#635 Effect of multi-biomarker panels based on urinary N-terminal osteopontin on prediction of diabetic kidney disease in patients with diabetes mellitus14
#2671 Renal tubular epithelial FFAR4 improves cellular senescence to alleviate interstitial fibrosis in CKD14
#2695 A Polycystin-1-Bicaudal C1 complex regulates focal adhesion function through integrin beta-1, F-actin organisation and local translation in HKE cells14
#2439 The association between vitamin D deficiency and sarcopenia in patients with pre-dialysis CKD14
#1795 Diverse histological findings of kidney injury in cancer patients on immunotherapy- impact on clinical management14
#1818 Association of combined systemic inflammatory indices with the severity and outcome of tunnelled hemodialysis catheter-related bacteremia14
#2917 Desensitization techniques in ABO-incompatible renal transplantation: efficacy and analysis of complications14
#675 Application of ANCA-associated vasculitis Histopathological Classification and Renal Risk Score for prediction of end-stage kidney disease14
#2388 Relevance of anti-PLA2R levels in therapy decision and prediction of therapy outcome in patients with membranous nephropathy14
#651 Diagnostiс criteria of the functional state of the kidneys in patients with type 2 diabetes mellitus14
#1916 Infective endocarditis in young female hemodialysis patient: a case report and literature review13
#2699 Rare glomerular microangiopathy: clinicopathological characteristics and prognosis13
#2529 The role of the circadian clock system in the transition from acute kidney injury to chronic kidney disease13
#1076 DNA hypomethylation of Syk induces oxidative stress and apoptosis via the PKCβ/ P66shc signaling pathway in diabetic kidney disease13
#972 A Novel Single Compound from Chinese Herbs as a Potential Candidate for Reducing obesity induced diabetic nephropathy via ATF3-RARRES1 axis pathway13
#2550 Micro(nano)plastics in human urine: a surprising contrast between Chongqing's urban and rural regions13
#289 Lipocalin-2 promotes cardiovascular calcification in chronic kidney disease by upregulating STAT3/NCOA4-mediated ferritinophagy and ferroptosis13
#1304 Clinical characteristics of acute kidney injury caused by Phytolaccaceae ingestion13
#1737 Kidney function, kidney function decline, and the risk of abdominal aortic aneurysm: the Stockholm CREAtinine Measurements (SCREAM) project13
#1839 Evaluating the severity of restless legs syndrome in chronic kidney disease patients across different renal replacement therapies13
#1846 Oxalate nephropathy in diabetic kidney disease: another factor to take into account?13
#2450 Alternative splicing in podocytes under mechanical stress: a new perspective for the pathogenic effect of glomerular hypertension13
#1716 IgA nephropathy: our center's experience13
#672 Intradialytic hypotension and adverse symptoms are not related13
#1683 Gut permeability, circulating bacterial fragments, and left ventricular strain in peritoneal dialysis13
#1834 Prevalence of nephrolithiasis in patients with idiopathic hypercalciuria after two decades of follow-up13
#2387 Case study of a patient with gouty nephropathy treated with immunosorbent therapy13
#1297 Approaches to renal response assessment in rare monoclonal immunoglobulin related glomerulopathies13
#1350 Finerenone in real-life clinical practice: first results from a pilot study13
#2984 SLE associated fibrillary glomerulonephritis vs SLE nephritis with fibrils: can a straightforward distinction always be made?12
Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in paediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport12
Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions in adults: a randomized controlled trial12
Metabolic dysfunction–associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease12
#2396 The potential of human-derived macrophages to study autosomal dominant polycystic kidney disease (ADPKD)12
#802 CENSUS-EU: a cross-sectional, study to assess the prevalence and burden of chronic kidney disease-associated pruritus in Europe12
#3055 Replacement of tunneled cuffed hemodialysis catheters on coated guidewire: a strategic approach to treat CVC-related infections12
#801 Impact of delayed graft function on cardiovascular events in kidney transplant recipients12
Transition of care of adolescent kidney transplant recipients—a call to action12
Long-term outcomes of COVID-19 survivors with hospital AKI: association with time to recovery from AKI12
Measuring quality of life in trials including patients on haemodialysis: methodological issues surrounding the use of the Kidney Disease Quality of Life Questionnaire12
#2556 Therapeutic monitoring in patients with APRT deficiency using UPLC-MS/MS-based plasma assay12
#1962 Development of triple-whammy induced pre-renal AKI is highly dependent on the hydration status12
#2116 Socioeconomic position and incidence of chronic kidney disease in Central Italy12
COVID-19 and ANCA-associated vasculitis: recommendations for vaccine preparedness and the use of rituximab12
Key enzyme in charge of ketone reabsorption of renal tubular SMCT1 may be a new target in diabetic kidney disease12
Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?12
#2967 C-reactive protein/serum chloride ratio: a novel marker of all-cause mortality in prevalent chronic haemodialysis patients12
#560 The representation of multimorbidity and frailty in the development and validation of kidney failure risk prediction models – a systematic review12
#1237 Management of dyslipidaemia with evolocumab in kidney transplant recipients12
Management of heart failure in patients with kidney disease—updates from the 2021 ESC guidelines11
Are patients with primary glomerular disease at increased risk of malignancy?11
Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy11
#2654 USE OF SUPERVISED DEEP LEARNING ALGORITHM TO PREDICT RISK OF RENAL REPLACEMENT THERAPY(RRT) IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD)11
MO790: Arteriovenous Fistula Calcifications—Risk Factors and Impact on Arteriovenous Fistula Functionality11
#3122 30-DAY COMPLICATIONS IN PERITONEAL DIALYSIS CATHETERS INSERTED PERCUTANEOUSLY VERSUS SURGICALLY IN A SECOND LEVEL HOSPITAL IN MERIDA, YUCATAN, MEXICO11
#4431 PREPARATION OF IMIDAZOLE QUATERNARY AMMONIUM SALT MICROSPHERES WITH HIGH BILIRUBIN ADSORPTION PERFORMANCE AND SELF-ANTICOAGULATION ABILITY11
#5703 COVID-19, RENAL DAMAGE AND ITS EVOLUTION IN HOSPITALISED PATIENTS IN THE FIRST WAVE OF THE PANDEMIC: EXPERIENCE OF ONE CENTRE11
#4204 MULTIPARAMETRIC MAGNETIC RESONANCE IMAGING BIOMARKERS OUTPERFORM LAB BIOMARKERS FOR PREDICTING PROGRESSION OF DIABETIC KIDNEY DISEASE11
MO218: Anca-Associated Vasculitis After SARS-COV-2 Vaccination in a Patient With HLA-DRB1*09: 01 ALLELE: A Case Report and Literature Review11
Long-term outcome of kidney function in patients with ANCA-associated vasculitis11
Time trends in preemptive kidney transplantation in Europe: an ERA registry study11
Non-crystalline light chain proximal tubulopathy, a morphologically protean entity11
MO341VALUE OF THE CELL CYCLE ARREST BIOMARKERS IN THE DIAGNOSIS OF PREGNANCY RELATED ACUTE KIDNEY INURY11
#4878 STUDYING THE EFFECTIVENESS OF PRASUGREL AND CLOPIDOGEL IN PATIENTS WITH CHRONIC LOWER LIMB ISCHEMIA WITH STAGE 2 CKD11
#3989 INTERACTIVE-HD 2.0 PROJECT – PRELIMINARY RESULTS OF LUGANO DATASET11
#3719 INCIDENCE, OUTCOMES AND RISK FACTORS OF ACUTE KIDNEY INJURY IN PATIENTS THAT UNDERWENT TRANSCATHETER AORTIC VALVE REPLACEMENT11
#5613 ASSESSMENT OF THE PROGRESSION OF CKD TAKING INTO ACCOUNT METABOLIC CHANGES11
#4535 CLINICAL CHARACTERISTICS AND OUTCOMES IN PATIENTS ABOVE THE AGE OF 65 WITH ANCA-ASSOCIATED VASCULITIS: A SINGLE CENTRE EXPERIENCE.11
MO171BARRIERS TO RENAL SUPPORTIVE CARE IN SINGAPORE: A SURVEY BASED STUDY OF NEPHROLOGISTS, GERIATRICIANS AND PALLIATIVE PHYSICIANS11
Incidence of acute kidney injury in relapsed and refractory multiple myeloma treated with teclistamab versus CAR-T cells11
CKD as a risk factor for severe COVID-19: a critical look back and lessons for the future11
Work status and work ability of patients receiving kidney replacement therapy: results from a European survey11
MO824PREDICTORS OF MORTALITY OF COVID-19 IN CHRONIC HEMODIALYSIS PATIENTS11
#4772 DOUBLE FILTRATION PLASMAPHERESIS DURING HETEROLOGOUS FERTILIZATION PREGNANCY FOR THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA11
#5852 EFFECT OF DIET ON THE COLLECTOR DUCT BEHAVIOUR: RELEVANCE IN PRECLINICAL DRUG DEVELOPMENT11
#4494 DRUG UTILIZATION FOLLOWING INCIDENT CHRONIC KIDNEY DISEASE: AN OBSERVATIONAL STUDY IN THE UNITED STATES AND JAPAN11
#4328 CHK-336, A FIRST-IN-CLASS ORALLY ADMINISTERED LDH INHIBITOR: SAFETY, PK AND TARGET ENGAGEMENT IN A FIRST-IN-HUMAN PHASE 1 HEALTHY VOLUNTEER STUDY11
#6738 ALCOHOL LOCK IN CRBSI: A PANACEA11
MO282EARLY RENAL RECOVERY AFTER A FIRST FLARE OF PAUCI IMMUNE GLOMERULONEPHRITIS11
Uromodulin biology11
MO088CLINICOPATHOLOGICAL FEATURES OF THROMBOTIC MICROANGIOPATHY10
#5734 RENAL AUTOLOGOUS CELL THERAPY (REACT™) FOR DIABETIC CHRONIC KIDNEY DISEASE: PHASE II TRIAL WITH BILATERAL CORTEX INJECTIONS AND RE-DOSING TRIGGERS10
#2999 APABETALONE REDUCES CARDIAC EVENTS IN CKD PATIENTS BY DOWNREGULATING FIBROTIC AND INFLAMMATORY PROCESSES10
#6050 TEMPORAL CHANGES IN PLASMA ENDOTHELIN-1 AND BLOOD PRESSURE DURING MAINTENANCE HAEMODIALYSIS10
#5213 RELATIONSHIP BETWEEN CYTOKINE RELEASE SYNDROME AND ACUTE KIDNEY INJURY AFTER CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY IN HEMATOLOGIC NEOPLASMS10
MO268: Use of Corticosteroids in a Norwegian Cohort of Patients with IGA Nephropathy and Rapid Progression to End-Stage Renal Disease10
#4152 CROSS-OMICS PROFILING OF PROTEOME, METABOLOME, AND TRANSCRIPTOME REVEALS MOLECULE AND CLEARANCE DYNAMICS AND ORIGIN IN PERITONEAL DIALYSIS10
#6153 SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS VERSUS DIPEPTIDYL PEPTIDASE 4 INHIBITORS AS STABILIZERS OF HIF PATHWAY IN DIABETIC NEPHROPATHY RATS10
#5902 KIDNEY INVOLVEMENT IN HAEMATOLOGICAL MALIGNANCIES: THE IMPORTANCE OF EARLY NEPHROLOGICAL REFERRAL10
#3930 EFFECT OF TWO PHOSPHATE BINDERS ON VITAMIN D LEVELS IN HEMODIALYSIS PATIENTS10
#5348 THE EFFECTS OF RITUXIMAB IN NON-HCV-RELATED MIXED CRYOGLOBULINEMIC VASCULITIS10
#2751 CD14++CD16+ monocytes and CD8+ T cells are independently associated with annual change in eGFR and proteinuria in kidney transplant recipients10
#3163 SARS-COV-2 OMICRON INFECTIONS AMONG VACCINATED MAINTENANCE HEMODIALYSIS PATIENTS: OUTCOMES AND COMPARISON TO DELTA VARIANT10
#4458 SINGLE CELL RNA SEQUENCING OF CIRCULATING LEUKOCYTES FROM IGA NEPHROPATHY PATIENTS IDENTIFIES AN IMPORTANT ROLE FOR INNATE IMMUNE CELLS10
#3447 ENVIRONMENTAL MELAMINE EXPOSURE AND ADVERSE KIDNEY OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS10
0.051423072814941